katal(830974)

Search documents
凯大催化(830974) - 2022 Q4 - 年度财报
2023-04-25 16:00
Financial Performance - The company's operating revenue for 2022 was CNY 1,982,523,522.63, representing a year-over-year increase of 15.85% compared to CNY 1,711,264,153.80 in 2021[35]. - The net profit attributable to shareholders for 2022 was CNY 67,991,994.56, which is a 9.25% increase from CNY 62,234,402.40 in 2021[35]. - The total assets as of the end of 2022 amounted to CNY 748,262,639.23, a decrease of 1.43% from CNY 759,095,955.22 at the end of 2021[37]. - The total liabilities decreased by 16.33% to CNY 185,356,756.95 in 2022 from CNY 221,538,067.50 in 2021[37]. - The cash flow from operating activities for 2022 was CNY 14,427,235.81, reflecting a significant decline of 85.93% compared to CNY 102,502,903.62 in 2021[39]. - The weighted average return on equity for 2022 was 12.44%, slightly up from 12.19% in 2021[35]. - The gross profit margin is influenced by customer structure, product structure, and fluctuations in precious metal prices, indicating a strong overall profitability despite a lower margin level[15]. - The gross profit margin for the company's main business was 4.92%, 4.99%, and 5.02% for the years 2020, 2021, and 2022 respectively, reflecting a relatively low level consistent with industry characteristics[14]. Customer and Supplier Concentration - The company reported sales to its top five customers amounting to RMB 1,604.35 million, representing 80.92% of total revenue, indicating a high customer concentration risk[13]. - The company has a high supplier concentration, which poses risks related to the stability of raw material quality and delivery times[12]. - The company’s major customers accounted for 80.92% of total sales, indicating a high concentration risk[80]. - The company’s major suppliers accounted for 64.03% of total purchases, highlighting a significant supplier concentration risk[82]. Research and Development - The company plans to continue investing in R&D for downstream applications in internal combustion engine exhaust purification, basic chemicals, and hydrogen energy to enhance industry position and product competitiveness[15]. - The company reported a research and development expenditure of 78,776,846.52 yuan, which accounted for 3.97% of operating income, up from 3.59% in the previous year[98]. - The company has a total of 22 R&D personnel, representing 29.85% of the total workforce, an increase from 28.95% in the previous year[100]. - The company is actively developing new products, including platinum-based catalysts, which have completed pilot and scale-up production[56]. - The company is focusing on the development of new generation platinum precursors that meet higher emission standards, ensuring product line upgrades[1]. - The company is developing a new generation of palladium-rhodium precursor for exhaust purification catalysts, aiming to meet higher emission standards[102]. - The company is collaborating with domestic chemical research institutes to promote palladium/alumina catalysts in coal and natural gas chemical sectors[54]. Strategic Initiatives - The company signed a strategic cooperation framework agreement with Shanghai Yihydrogen Technology Co., Ltd. to develop a new platinum-based catalyst for hydrogen energy batteries, aiming to create a new profit growth point[5]. - The company aims to deepen strategic cooperation with upstream industries to enhance its competitive edge in the precious metals recycling industry[31]. - The company has established a new subsidiary, Kaida Resources, with a registered capital of CNY 50 million, holding a 51% stake, to enhance its capabilities in precious metal refining and processing[30][31]. - The company is expanding its production capacity with a new facility expected to add 200 tons of precious metal catalyst production annually upon completion[55]. - The company is actively expanding into the hydrogen fuel cell catalyst materials sector, with a target of 100,000 hydrogen fuel cell vehicles in China by 2025, creating substantial market demand[62]. Risks and Challenges - The company faces risks related to the volatility of precious metal prices, which constitute over 99% of its operating costs, impacting both revenue and profitability[14]. - The company is exposed to risks associated with the potential shortage of precious metal resources due to reliance on imports and geopolitical factors[14]. - The company has faced risks related to technology innovation, including high difficulty, large investment, and long cycles for new product development, which could adversely affect market position and profitability[15]. - The company is exposed to risks from potential shortages of precious metal resources and significant fluctuations in gross profit margins due to market competition[16]. - The company has identified new risk factors, including risks related to import substitution and core technology leakage, and has conducted a systematic analysis of these risks[141]. Corporate Governance and Control - The actual controllers hold a combined 33.2048% of the shares, which poses a risk to the stability of the company's control if the agreement is not renewed[16]. - The company signed a "consensus action agreement" to ensure the stability of control, which is effective for 36 months post-IPO[140]. - The company has implemented measures to improve internal control and risk prevention capabilities, ensuring compliance with legal and regulatory requirements[128]. - The company has established a framework for managing related party transactions and external guarantees, ensuring compliance with relevant regulations[155]. - The controlling shareholders have pledged to minimize related party transactions and ensure they are conducted at fair market prices[157]. Market Position and Competitive Edge - The company aims to replace imported products with its self-developed products, competing with international chemical giants in terms of quality and performance[14]. - The company has achieved stable quality and good performance in its main product, automotive exhaust purification catalysts, gradually replacing foreign products[59]. - The company is committed to continuous innovation in precious metal catalytic materials, enhancing its R&D team and collaborating with academic institutions to strengthen its competitive edge[127]. - The company has established a significant market entry barrier through its advanced analysis and detection systems for precious metal catalysts[192]. - The company is focusing on the development of new palladium/alumina catalysts, with 2 tons of platinum/alumina catalysts provided for trial use, showing stable performance and potential as a new growth point[123]. Inventory and Asset Management - The company has established a relatively complete inventory management system, primarily adopting a "sales-based production and order-based procurement" model to mitigate the risk of precious metal price fluctuations[15]. - The inventory turnover rate improved to 8.52 in 2022 from 7.63 in 2021[39]. - The ending inventory value of Kaida Catalytic Company is ¥185,164,430.12, accounting for 24.75% of total assets[109]. - The company has improved its raw material separation and purification technology, enhancing its profit margins while expanding its resource base[135]. Shareholder and Equity Information - The company issued 11.5 million new shares, increasing its total share capital from 152.3 million to 163.8 million shares following its listing on the Beijing Stock Exchange[29]. - The total share capital remains unchanged at 152,300,000 shares, with 306 shareholders reported[184]. - The largest shareholder, Yao Hong, holds 22,855,369 shares, representing 15.01% of total shares[187]. - The second-largest shareholder, Zheng Gang, holds 7,850,000 shares, which is 5.15% of total shares, reflecting a decrease of 10,000 shares[187]. - The company has clarified that there are no direct or indirect equity relationships with its underwriting and auditing institutions, ensuring transparency[178].
凯大催化(830974) - 2023 Q1 - 季度财报
2023-04-25 16:00
Financial Performance - Net profit attributable to shareholders for Q1 2023 was CNY 14.67 million, a decrease of 38.70% compared to CNY 23.92 million in Q1 2022[10] - Operating revenue for Q1 2023 was CNY 389.69 million, down 32.07% from CNY 573.64 million in the same period last year[10] - The total comprehensive income for the period was CNY 12,546,459.89, compared to CNY 23,759,453.70 in the previous period[46] - Total operating revenue for Q1 2023 was CNY 389.69 million, a decrease of 32.2% compared to CNY 573.64 million in Q1 2022[40] - Total operating costs for Q1 2023 were CNY 370.98 million, down from CNY 545.40 million in Q1 2022, reflecting a cost reduction of 32.0%[40] - Net profit for Q1 2023 was CNY 14.67 million, a decline of 38.7% from CNY 23.92 million in Q1 2022[42] - Earnings per share for Q1 2023 were CNY 0.09, compared to CNY 0.16 in Q1 2022, indicating a 43.8% decrease[42] Assets and Liabilities - Total assets as of March 31, 2023, amounted to CNY 757.63 million, reflecting a 1.25% increase from CNY 748.26 million at the end of 2022[10] - The company’s total liabilities to total assets ratio (consolidated) improved to 16.93% from 24.77% at the end of the previous year[10] - Total liabilities decreased to ¥128,242,420.53 from ¥185,356,756.95, a reduction of about 30.73%[34] - The company’s total assets reached CNY 815.33 million, up from CNY 752.28 million, marking an increase of 8.4%[38] - Total equity increased to CNY 612.93 million from CNY 548.57 million, representing an increase of 11.7%[38] Cash Flow - The company's cash flow from operating activities showed a net inflow of CNY 21.55 million, a significant improvement of 134.63% compared to a net outflow of CNY 62.23 million in the previous year[10][14] - Cash inflow from operating activities was CNY 428,097,491.73, down from CNY 506,187,591.70 year-over-year, representing a decrease of approximately 15.4%[47] - The net cash flow from operating activities was CNY 21,546,869.84, a significant improvement from a net outflow of CNY 62,228,327.99 in the same period last year[47] - The ending cash and cash equivalents balance was CNY 215,353,899.90, up from CNY 176,327,629.87 year-over-year[48] - The company reported a decrease in cash received from sales of goods and services to CNY 423,198,699.31 from CNY 496,176,465.78, reflecting a decline of approximately 14.7%[47] Shareholder Information - The total shareholding of the top ten shareholders is 66,786,162 shares, representing 41.15% of the total shares[21] - The largest shareholder, Yao Hong, holds 22,855,369 shares, accounting for 14.08% of the total shares[21] - The second-largest shareholder, Zheng Gang, holds 7,850,000 shares, which is 4.84% of the total shares[21] - The total number of shares held by the top ten shareholders decreased by 478,338 shares during the reporting period[21] Borrowings and Financing - Short-term borrowings decreased by 86.21%, indicating a reduction in short-term financing needs[12] - The company’s long-term borrowings increased by 998.73% due to obtaining a three-year bank loan[12] - The company reported a significant reduction in short-term borrowings from ¥46,400,000.00 to ¥6,400,000.00, a decrease of approximately 86.16%[33] - The net cash flow from financing activities was CNY 50,298,888.10, compared to CNY 9,649,375.00 in the previous year, indicating a substantial increase[48] Operational Insights - The company reported a credit impairment loss of CNY 1.57 million in Q1 2023, compared to CNY 0.17 million in Q1 2022, indicating a significant increase in credit risk[41] - Research and development expenses for Q1 2023 were CNY 1.60 million, up from CNY 1.26 million in Q1 2022, showing a growth of 27.0%[41] - The company is focusing on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[34] - The company plans to focus on market expansion and new product development to drive future growth[40] Legal and Compliance - The company has no ongoing litigation or arbitration matters during the reporting period[24] - There are no external guarantees or loans provided by the company during the reporting period[24] - The company has fulfilled all disclosed commitments without any overdue situations[26] - The company has not engaged in any significant related party transactions during the reporting period[24] - There are no assets that have been seized, frozen, or pledged during the reporting period[24] - The company has not faced any investigations or penalties during the reporting period[24]
凯大催化:招股说明书
2023-02-20 14:02
证券简称:凯大催化证券代码:830974 浙江省杭州市拱墅区康桥路 7 号 101 室 杭州凯大催化金属材料股份有限公司 杭州凯大催化金属材料股份有限公司招股说明书(申报稿) 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行股票的法律 效力,投资者应当以正式公告的招股说明书全文作为投资决定的依据。 本次股票发行后拟在北京证券交易所上市,该市场具有较高的投资风险。北京证券交易所主 要服务创新型中小企业,上市公司具有经营风险高、业绩不稳定、退市风险高等特点,投资者面 保荐人(主承销商) (成都市青羊区东城根上街 95 号) 1-1-1 临较大的市场风险。投资者应充分了解北京证券交易所市场的投资风险及本公司所披露的风险因 素,审慎作出投资决定。 中国证监会和北京证券交易所对本次发行所作的任何决定或意见,均不表明其对注册 申请文件及所披露信息的真实性、准确性、完整性作出保证,也不表明其对发行人的盈利 能力、投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属 虚假不实陈述。 根据《证券法》的规定,股票依法发行后,发行人经营与收益的变化,由发行人自行 负责;投资者自主判断发行人 ...
凯大催化:招股说明书(注册稿)
2023-01-31 23:04
证券简称:凯大催化证券代码:830974 浙江省杭州市拱墅区康桥路 7 号 101 室 杭州凯大催化金属材料股份有限公司 杭州凯大催化金属材料股份有限公司招股说明书(申报稿) 效力,投资者应当以正式公告的招股说明书全文作为投资决定的依据。 本次股票发行后拟在北京证券交易所上市,该市场具有较高的投资风险。北京证券交易所主 要服务创新型中小企业,上市公司具有经营风险高、业绩不稳定、退市风险高等特点,投资者面 临较大的市场风险。投资者应充分了解北京证券交易所市场的投资风险及本公司所披露的风险因 素,审慎作出投资决定。 保荐人(主承销商) (成都市青羊区东城根上街 95 号) 1-1-1 本公司的发行申请尚未经中国证监会注册。本招股说明书申报稿不具有据以发行股票的法律 中国证监会和北京证券交易所对本次发行所作的任何决定或意见,均不表明其对注册 申请文件及所披露信息的真实性、准确性、完整性作出保证,也不表明其对发行人的盈利 能力、投资价值或者对投资者的收益作出实质性判断或者保证。任何与之相反的声明均属 虚假不实陈述。 根据《证券法》的规定,股票依法发行后,发行人经营与收益的变化,由发行人自行 负责;投资者自主判断发行人 ...